Navigation Links
HPV-Positive Head and Neck Cancers Fare Better
Date:2/12/2008

Patients survive longer, more responsive to treatment than those with HPV-negative tumors

TUESDAY, Feb. 12 (HealthDay News) -- Head and neck cancer patients whose tumors test positive for human papillomavirus (HPV) tend to survive longer and respond better to treatment than those who test negative, a new study says.

HPV, a common virus with strains believed to be responsible for most cervical cancers, has recently been linked to the development of some head and neck cancers, particularly those of the upper throat, or oropharynx.

Researchers followed 96 patients in the late stages of cancer of the oropharynx or larynx (voice box), according to a study published online Feb. 12 in the Journal of the National Cancer Institute. All the patients were enrolled in the same clinical trial and received the same treatment.

Patients with HPV-positive tumors had higher response rates after chemoradiation therapy, compared with patients with HPV-negative tumors (84 percent vs. 57 percent). The two-year overall survival rates of those with HPV-positive tumors were also higher (95 percent vs. 62 percent).

"Our data suggest that the risks and benefits of therapies should be considered separately for HPV-positive and -negative patients," the authors wrote.

More information

To learn more about head and neck cancers, visit the National Cancer Institute.



-- Kevin McKeever



SOURCE: Journal of the National Cancer Institute, news release, Feb. 12, 2008


'/>"/>
Copyright©2008 ScoutNews,LLC.
All rights reserved  

Page: 1

Related medicine news :

1. Study reveals why certain ovarian cancers develop resistance to platinum-based chemotherapy
2. NuView Radiopharmaceuticals, Inc. Secures Exclusive Rights From Thomas Jefferson University for a Tumor-Specific Imaging Agent for the Diagnosis of Breast and Prostate Cancers
3. American Tailgaters Association, ESPNs Sean Salisbury and George Foreman Unite in the Fight Against Pediatric Cancers Around Super Bowl XLII
4. How less can be more when treating some kidney cancers
5. Cell Addiction to Growth Factors May Help Spur Cancers
6. The 2008 Gastrointestinal Cancers Symposium
7. Sperms immune-protection properties could provide link to how cancers spread
8. Survey points out need for education for primary care physicians on rarely seen cancers
9. Obesity, Diabetes Linked to Cancers
10. AMAS Test Measures Lethal Replikin Gene Activity in Lung and Other Cancers
11. Breast MRI spots other cancers, may alter treatment plan
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
HPV-Positive Head and Neck Cancers Fare Better 
HPV-Positive Head and Neck Cancers Fare Better
Breaking Medicine News(10 mins):Health News:Moses Cone Health System Selects Streamline Health to Enhance the Electronic Medical Record 2Health News:Moses Cone Health System Selects Streamline Health to Enhance the Electronic Medical Record 3Health News:Moses Cone Health System Selects Streamline Health to Enhance the Electronic Medical Record 4Health News:Frost & Sullivan to Hold Web Conference on Integrated Hospital Pharmacy Information Systems - How to Maneuver towards Growth Potential 2Health News:OrderOnlineDrugs.com Makes Ordering Drugs Online Safe and Affordable 2Health News:Frost & Sullivan: E-Healthcare in Western Europe Presents a Significant Market Opportunity for Wireless Technologies 2Health News:Frost & Sullivan: E-Healthcare in Western Europe Presents a Significant Market Opportunity for Wireless Technologies 3Health News:Study Finds Family Members Play Critical Role in Addressing Loved Ones' Hearing Loss 2Health News:Study Finds Family Members Play Critical Role in Addressing Loved Ones' Hearing Loss 3Health News:Study Finds Family Members Play Critical Role in Addressing Loved Ones' Hearing Loss 4
Breaking Medicine Technology:FDA Makes Interim Recommendations to Address Concern of Excess Radiation Exposure during CT Perfusion Imaging 2FDA Makes Interim Recommendations to Address Concern of Excess Radiation Exposure during CT Perfusion Imaging 3Stallergenes: Oralair: Very Positive 3-Year Results of the Long-Term Study 2Stallergenes: Oralair: Very Positive 3-Year Results of the Long-Term Study 3Stallergenes: Oralair: Very Positive 3-Year Results of the Long-Term Study 4Stallergenes: Oralair: Very Positive 3-Year Results of the Long-Term Study 5Hill-Rom Announces Appointment of James R. Giertz to Board of Directors 2Cardium Announces Commercial Development of Excellagen 28TM 29 a Customized Collagen Based Topical Gel for Initial Use as an Adjunct to Surgical Debri 59439 1Cardium Announces Commercial Development of Excellagen 28TM 29 a Customized Collagen Based Topical Gel for Initial Use as an Adjunct to Surgical Debri 59439 2Cardium Announces Commercial Development of Excellagen 28TM 29 a Customized Collagen Based Topical Gel for Initial Use as an Adjunct to Surgical Debri 59439 3Cardium Announces Commercial Development of Excellagen 28TM 29 a Customized Collagen Based Topical Gel for Initial Use as an Adjunct to Surgical Debri 59439 4Cardium Announces Commercial Development of Excellagen 28TM 29 a Customized Collagen Based Topical Gel for Initial Use as an Adjunct to Surgical Debri 59439 5Cardium Announces Commercial Development of Excellagen 28TM 29 a Customized Collagen Based Topical Gel for Initial Use as an Adjunct to Surgical Debri 59439 6Cardium Announces Commercial Development of Excellagen 28TM 29 a Customized Collagen Based Topical Gel for Initial Use as an Adjunct to Surgical Debri 59439 7Cardium Announces Commercial Development of Excellagen 28TM 29 a Customized Collagen Based Topical Gel for Initial Use as an Adjunct to Surgical Debri 59439 8Somanetics Acquires Exclusive Sublicense to Cerebral Autoregulation Monitoring Technology Developed at The Johns Hopkins University 5466 1Somanetics Acquires Exclusive Sublicense to Cerebral Autoregulation Monitoring Technology Developed at The Johns Hopkins University 5466 2Somanetics Acquires Exclusive Sublicense to Cerebral Autoregulation Monitoring Technology Developed at The Johns Hopkins University 5466 3Somanetics Acquires Exclusive Sublicense to Cerebral Autoregulation Monitoring Technology Developed at The Johns Hopkins University 5466 4Somanetics Acquires Exclusive Sublicense to Cerebral Autoregulation Monitoring Technology Developed at The Johns Hopkins University 5466 5Video 3A EmFinders EmSeeQ 28TM 29 Now Available to Locate Wandering Individuals in Emergency Situations Nationwide 5461 1Video 3A EmFinders EmSeeQ 28TM 29 Now Available to Locate Wandering Individuals in Emergency Situations Nationwide 5461 2Video 3A EmFinders EmSeeQ 28TM 29 Now Available to Locate Wandering Individuals in Emergency Situations Nationwide 5461 3Video 3A EmFinders EmSeeQ 28TM 29 Now Available to Locate Wandering Individuals in Emergency Situations Nationwide 5461 4